These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17042328)

  • 21. Design, synthesis, biological evaluation, and molecular modeling studies of TIBO-like cyclic sulfones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Di Santo R; Costi R; Artico M; Ragno R; Lavecchia A; Novellino E; Gavuzzo E; La Torre F; Cirilli R; Cancio R; Maga G
    ChemMedChem; 2006 Jan; 1(1):82-95. PubMed ID: 16892340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.
    Masuda N; Yamamoto O; Fujii M; Ohgami T; Fujiyasu J; Kontani T; Moritomo A; Orita M; Kurihara H; Koga H; Kageyama S; Ohta M; Inoue H; Hatta T; Shintani M; Suzuki H; Sudo K; Shimizu Y; Kodama E; Matsuoka M; Fujiwara M; Yokota T; Shigeta S; Baba M
    Bioorg Med Chem; 2005 Feb; 13(4):949-61. PubMed ID: 15670903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor.
    Dousson C; Alexandre FR; Amador A; Bonaric S; Bot S; Caillet C; Convard T; da Costa D; Lioure MP; Roland A; Rosinovsky E; Maldonado S; Parsy C; Trochet C; Storer R; Stewart A; Wang J; Mayes BA; Musiu C; Poddesu B; Vargiu L; Liuzzi M; Moussa A; Jakubik J; Hubbard L; Seifer M; Standring D
    J Med Chem; 2016 Mar; 59(5):1891-8. PubMed ID: 26804933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Alexandre FR; Amador A; Bot S; Caillet C; Convard T; Jakubik J; Musiu C; Poddesu B; Vargiu L; Liuzzi M; Roland A; Seifer M; Standring D; Storer R; Dousson CB
    J Med Chem; 2011 Jan; 54(1):392-5. PubMed ID: 21142105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
    Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
    Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates.
    Samuele A; Bisi S; Kataropoulou A; La Regina G; Piscitelli F; Gatti V; Silvestri R; Maga G
    Antivir Chem Chemother; 2011 Nov; 22(3):107-18. PubMed ID: 22095519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
    Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
    J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
    Di Santo R; Costi R; Artico M; Miele G; Lavecchia A; Novellino E; Bergamini A; Cancio R; Maga G
    ChemMedChem; 2006 Dec; 1(12):1367-78. PubMed ID: 17089433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of novel 3,5-disubstituted-1,2,6-thiadiazine-1,1-dione derivatives as HIV-1 NNRTIs.
    Tian Y; Rai D; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu H; Liu X
    Chem Biol Drug Des; 2013 Oct; 82(4):384-93. PubMed ID: 23659687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
    Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R
    ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2H-Pyrrolo[3,4-b] [1,5]benzothiazepine derivatives as potential inhibitors of HIV-1 reverse transcriptase.
    Di Santo R; Costi R
    Farmaco; 2005 May; 60(5):385-92. PubMed ID: 15910811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
    Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
    J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of novel trifluoromethyl indoles as potent HIV-1 NNRTIs with an improved drug resistance profile.
    Jiang HX; Zhuang DM; Huang Y; Cao XX; Yao JH; Li JY; Wang JY; Zhang C; Jiang B
    Org Biomol Chem; 2014 Jun; 12(21):3446-58. PubMed ID: 24752610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs).
    Zhao Z; Wolkenberg SE; Sanderson PE; Lu M; Munshi V; Moyer G; Feng M; Carella AV; Ecto LT; Gabryelski LJ; Lai MT; Prasad SG; Yan Y; McGaughey GB; Miller MD; Lindsley CW; Hartman GD; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2008 Jan; 18(2):554-9. PubMed ID: 18083561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Schenone S; Bruno O; Bondavalli F; Vargiu L; Marceddu T; Mura M; La Colla P; Pani A
    J Med Chem; 2003 Feb; 46(5):768-81. PubMed ID: 12593657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928).
    Li X; Gao P; Zhan P; Liu X
    Expert Opin Ther Pat; 2016 May; 26(5):629-35. PubMed ID: 26742549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.
    Samuele A; Crespan E; Vitellaro S; Monforte AM; Logoteta P; Chimirri A; Maga G
    Antiviral Res; 2010 Jun; 86(3):268-75. PubMed ID: 20307579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.